Sponsor

Breast Cancer Canada, in partnership with AstraZeneca

For More Information

See Breast Cancer Canada's website for full application information, guidelines, and LOI Application Form.

Description

Breast Cancer Canada (BCC) and AstraZeneca Canada (AZC) have partnered to offer two research grants advancing studies on treatment resistance, rapid relapses and long-term responses in HR+/HER2- and HER2+ metastatic breast cancer. This new partnership aims to drive progress in care for patients with late-stage breast cancer.

 

Eligibility

Submitted Project must include:

  • Include at a minimum, 1 clinician and 1 form of breast cancer patient advocate (individual or organized group) as advisors to the research project.
  • Incorporate principles of precision oncology
  • Use of AI / machine learning
  • Impact plan within next 3 years
  • Detailed Budget

Funding Availability

Two Research Grants Available:  Each Grant will include $100,000 of funding 

Indirect Costs

0% per sponsor policy

Deadlines

If College-level review is required, your College will communicate its earlier internal deadlines.

TypeDateNotes
External Deadline

Applicant to submit Letter of Intent using sponsor template to BCC directly via email at: research@breastcancerprogress.ca

Internal Deadline

Applicant to submit completed application with signed OR-5 form to Research Support Services via email at research.services@uoguelph.ca

External Deadline

Applicant to submit Full and Final Application to BCC directly via email at: research@breastcancerprogress.ca

For Questions, please contact

Email sponsor at: research@breastcancerprogress.ca 

Office of Research

Laurie Green, Awards & Agreements Officer
Research Services Office
lagreen@uoguelph.ca

Alert Classifications
Category:
Funding Opportunities and Sponsor News

Disciplines:
Health and Life Sciences
Physical Sciences and Engineering